AU2729597A - Transgenic plants with enhanced sulfur amino acid content - Google Patents
Transgenic plants with enhanced sulfur amino acid contentInfo
- Publication number
- AU2729597A AU2729597A AU27295/97A AU2729597A AU2729597A AU 2729597 A AU2729597 A AU 2729597A AU 27295/97 A AU27295/97 A AU 27295/97A AU 2729597 A AU2729597 A AU 2729597A AU 2729597 A AU2729597 A AU 2729597A
- Authority
- AU
- Australia
- Prior art keywords
- sulfur
- rich
- plant
- gene
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000011593 sulfur Substances 0.000 title claims description 55
- 229910052717 sulfur Inorganic materials 0.000 title claims description 55
- 230000009261 transgenic effect Effects 0.000 title claims description 43
- -1 sulfur amino acid Chemical class 0.000 title description 3
- 241000196324 Embryophyta Species 0.000 claims description 94
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 53
- 235000007164 Oryza sativa Nutrition 0.000 claims description 39
- 241000209094 Oryza Species 0.000 claims description 38
- 108060006613 prolamin Proteins 0.000 claims description 38
- 235000009566 rice Nutrition 0.000 claims description 38
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 29
- 241000208818 Helianthus Species 0.000 claims description 28
- 101710168820 2S seed storage albumin protein Proteins 0.000 claims description 25
- 244000068988 Glycine max Species 0.000 claims description 25
- 150000001413 amino acids Chemical class 0.000 claims description 22
- 239000002773 nucleotide Substances 0.000 claims description 21
- 125000003729 nucleotide group Chemical group 0.000 claims description 21
- 239000013604 expression vector Substances 0.000 claims description 19
- 230000014509 gene expression Effects 0.000 claims description 19
- 108020004414 DNA Proteins 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 7
- 230000001965 increasing effect Effects 0.000 claims description 6
- 102000053602 DNA Human genes 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 4
- 235000019764 Soybean Meal Nutrition 0.000 claims description 3
- 239000004455 soybean meal Substances 0.000 claims description 3
- 230000001902 propagating effect Effects 0.000 claims description 2
- 241001057636 Dracaena deremensis Species 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 description 71
- 239000002609 medium Substances 0.000 description 36
- 235000018102 proteins Nutrition 0.000 description 27
- 102000004169 proteins and genes Human genes 0.000 description 27
- 230000009466 transformation Effects 0.000 description 26
- 235000010469 Glycine max Nutrition 0.000 description 21
- 235000001014 amino acid Nutrition 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 18
- 239000013598 vector Substances 0.000 description 13
- 244000061176 Nicotiana tabacum Species 0.000 description 12
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 12
- 240000008042 Zea mays Species 0.000 description 11
- 239000003550 marker Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 8
- 235000005822 corn Nutrition 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 239000003623 enhancer Substances 0.000 description 7
- 241001233957 eudicotyledons Species 0.000 description 7
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- 241000209510 Liliopsida Species 0.000 description 6
- 108010059993 Vancomycin Proteins 0.000 description 6
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 6
- 108010047974 brazil nut 2S albumin Proteins 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 229960003165 vancomycin Drugs 0.000 description 6
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 6
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 101150085703 vir gene Proteins 0.000 description 5
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 4
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 108010025815 Kanamycin Kinase Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 4
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 229960004261 cefotaxime Drugs 0.000 description 4
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108091029865 Exogenous DNA Proteins 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 235000021186 dishes Nutrition 0.000 description 3
- 239000012877 elongation medium Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000031787 nutrient reservoir activity Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- 101710097209 2S seed storage protein 1 Proteins 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 101710163504 Phaseolin Proteins 0.000 description 2
- 108010016634 Seed Storage Proteins Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- DFYRUELUNQRZTB-UHFFFAOYSA-N apocynin Chemical compound COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- ZTBAPEIDNUHRNC-UHFFFAOYSA-N danielone Chemical compound COC1=CC(C(=O)CO)=CC(OC)=C1O ZTBAPEIDNUHRNC-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000012248 genetic selection Methods 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000012499 inoculation medium Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 2
- 229960002064 kanamycin sulfate Drugs 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 239000012882 rooting medium Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 229940027257 timentin Drugs 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 101710138363 10 kDa prolamin Proteins 0.000 description 1
- 101710154545 16 kDa protein Proteins 0.000 description 1
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 1
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000012284 Bertholletia excelsa Nutrition 0.000 description 1
- 244000205479 Bertholletia excelsa Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 229940122644 Chymotrypsin inhibitor Drugs 0.000 description 1
- 101710137926 Chymotrypsin inhibitor Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 101710198774 Envelope protein US9 Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241001058146 Erium Species 0.000 description 1
- 241000701484 Figwort mosaic virus Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 239000005980 Gibberellic acid Substances 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241001608711 Melo Species 0.000 description 1
- 101710196226 Methionine-rich protein Proteins 0.000 description 1
- 101000966481 Mus musculus Dihydrofolate reductase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 108700011203 Phaseolus vulgaris phaseolin Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 101150039863 Rich gene Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108050007496 Shikimate kinase 2 Proteins 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 101710101744 Sulfur-rich protein Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 108010083912 bleomycin N-acetyltransferase Proteins 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000003541 chymotrypsin inhibitor Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- APVPOHHVBBYQAV-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 APVPOHHVBBYQAV-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100001160 nonlethal Toxicity 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 108010008664 streptomycin 3''-kinase Proteins 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 1
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
- C12N15/8253—Methionine or cysteine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fertilizers (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
TRANSGENIC PLANTS WITH ENHANCED SULFUR AMINO ACID CONTENT
FIELD OF THE INVENTION
The present invention relates to transgenic plants that have elevated levels of sulfur-containing amino acids. More specifically, the invention relates to the production of transgenic plants that contain a DNA segment with a coding sequence corresponding to that of a gene for a sulfur-rich rice prolamin or sunflower 2S albumin protein.
BACKGROUND OF THE INVENTION Many animal feed formulations are based on soybean or corn, which provides a concentrated source of protein. Soybean meal in particular lacks the essential sulfur- containing amino acids, methionine and cysteine, because the most abundant proteins accumulated in soybean seeds are deficient in these amino acids. Supplementation of animal feeds based on soybean or corn to bring the levels of essential sulfur-containing amino acids up to that required is a significant added expense.
Sulfur content of animal feed formulations based on soybeans has been increased by using soybeans transformed to express Brazil nut 2S albumin gene. The Brazil nut 2S albumin protein is a seed storage protein that is high in sulfur-containing amino acids, containing 18 mol per cent methionine and eight mol per cent cysteine. Since the Brazil nut 2S albumin is largely responsible for Brazil nut allergenicity, however, the use of seed from soybean plants transformed to express the Brazil nut 2S albumin gene is an unacceptable method of raising the sulfur content of animal feeds based on soybeans.
Brazil nut 2S albumin is a member of a superfamily of homologous proteins hypothesized to have a common ancestral qene(s) . Kreis et al . , J. Mol . Biol . 183: 499 (1985) . Many other seeds that have 2S albumin storage proteins are known to contain- potent allergens. Melo et al . , Food & Agricul tural Immunology 6: 185 (1994) . This
is not surprising, given the degree of homology of 2S albumin storage proteins.
Monocot plants also contain seed storage proteins. The predominant storage proteins in most of the agronomically important cereals are the prolamins . Rice and oats are unusual cereal crops, in that the major storage protein is an US-type globulin, and only small amounts of prolamin proteins are found. Fewer monocot genes have been introduced successfully into dicot plants, for several reasons. There are definite differences in seed composition, gene regulation and post transciptional processing of storage proteins in dicots and monocots. In particular, monocot promoters typically do not function well in dicots. Other concerns relate to the stability of the sulfur-rich gene in the seed, and possible affects of the introduced gene on normal development of the plant. Altenbach et al . , TIBTECH 8: 156 (1990) .
SUMMARY OF THE INVENTION It is therefore an object of the present invention to provide plants that express an exogenous DNA sequence encoding a protein which is high in sulfur-containing amino acids but which does not cause an allergenic reaction i. humans or animals. It also is an object of the present invention to provide a method of increasing the content of sulfur- containing amino acids in an animal feed without supplementation.
It also is an object of the present invention to provide ar approach for altering a plant so that it produces seeds characterized by levels of sulfur- containing amino acids that are higher than those of plants that have not been so altered.
In accomplishing these and other objectives, there has been provided, in accordance with one aspect of the present invention, a transgenic plant that contains a DNA molecule comprised of (A) a nucleotide sequence corresponding to a sulfur-rich rice prolamin gene or
sulfur-rich sunflower 2S albumin gene and (B) a promoter, operably linked to the nucleotide sequence, to effect expression thereof by the transgenic plant. The transgenic plant preferably is a corn or soybean plant. A preferred rice prolamin gene is a sulfur-rich 10 kDa rice prolamin gene, while a preferred sunflower 2S albumin gene is SFA-7 and SFA-8, preferably SFA-8. The invention also provides seeds produced by the transgenic plants. A method of altering a plant to produce seed that contains levels of sulfur-containing amino acids that are higher than those of an unaltered plant is provided, comprising steps of (i) providing cells or tissues of a plant transformed with an expression vectoi that contains a nucleotide sequence corresponding to a sulfur-rich rice prolamin gene or sulfur-rich sunflower 2S albumin gene;
(ii) propagating plants from the transformed cells or tissue; and (iv) selecting for further propagation those plants that produce sulfur-rich rice prolamin or sulfur- rich sunflower 2S albumin.
A method also is provided for increasing the content of sulfur-containing amino acids in an animal feed, preferably without supplementation, which comprises steps of (i) providing seeds from a plurality of plants, at least some of which plants contain a DNA molecule comprised of a nucleotide sequence corresponding to a sulfur-rich rice prolamin gene or sulfur-rich sunflower 2S albumin gene, operably linked to a promoter to effect expression of the nucleotide sequence by the plants; and (ii) processing the seeds into animal feed. The method results in a feed product that has not been supplemented by addition of sulf r-containing amino acids and that contains soybean or corn meal obtained from seed of transgenic plants. Other objects, features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples,
while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invent Lon will become apparent to thuse skilled in the art from this detailed description.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is the nucleotide and deduced amino acid sequence of sunflower 2S albumin 8 (SFA-8) .
Figure 2 is the nucleotide and deduced amino acid sequence of the 10 kDa rice prolamin clone.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention allows for the production of transgenic plants that bear seeds characterized by a higher content of sulfur-containing amino acids, relative to plants that lack the heterologous DNA in question. Thus, an enhanced sulfur content in soybean ( Glycine max) or corn (Zea mays) , for example, is achieved, without significant allergenicity problems, by transforming soybean oi corn material with a heterologous DNA segment that has a nucleotide sequence corresponding to one or more copies of a gene for a rice { Oryza sativa L) 10 kDa or 16 kDa prolamin or a sunflower (Helianthus annus L) 2S albumin protein, which are rich in sulfur.
In view of the similarity between the Brazil nut 2S albumin protein and its sunflower homolog, it is surprising that the sulfur-rich sunflower 2S albumin protein does not cause allergenicity problems . It also is surprising that a prolamin gene from rice, a monocot, can be successfully expressed in soybean, a dicot, without stability problems.
Sulfur-rich sunflower 2S albumin proteins are described, by example, by Lilley et al . , "Isolation and Primary Structure for a Novel Methionine-rich Protein from Sunflowerseeds (Helianthus annus . L) , " in PROCEEDINGS OF THE WORLD CONGRESS ON VEGETABLE PROTEIN UTILIZATION IN HUMAN FOODS AND ANIMAL FEEDSTUFFS 497-502 (1989) , and by Kortt et al . , Phytoche istry 29: 2805 (1990) , the respective contents of which are incorporated herein by reference.
Eight proteins, denoted sunflower albumins (SFA) 1 to 8, are identified in the 2S albumin fraction. Two of these, SFA-7 and SFA-8, are sulfur-rich. They contain about eight mol per cent cysteine and 16 mol per cent methionine. SFA-8 is present in greater amounts than SFA-7, and for this reason is preferred. The nucleotide sequence of SFA-8 is shown in Figure 1.
Matsumura et al., Plan t Molec . Biol . 12: 123 (1989) , describe three prolamin polypeptides isolated from rice seeds, denoted "10 kDa," "13 kDa" and "16 kDa." The 10 kDa and 16 kDa proteins are said to be sulfur-rich. A full-length clone for the 10 kDa prolamin also is described, and this embodiment is preferred for use according to the present invention. The nucleotide sequence of the 10 kDa clone is shown in Figure 2.
In accordance with the present invention, a DNA molecule comprising a transformation/expression vector is engineered to include a sequence from one of the sulfur- rich sunflower 2S albumin genes or from the 10 kDa or 16 kDa sulfur-rich rice prolamin gene. Isolation and cloning of these genes by standard methodology is described in Lilley et al . , Kortt et al . and Matsumura et al . , supra . The rice prolamin genes first may be modified to reflect preferred codon usage in dicots, prior to introduction into soybean.
The sulfur-rich sunflower 2S albumin genes and the 10 kDa or 16 kDa sulfur-rich rice prolamin gene of the present invention can be isolated from a natural source or synthesized from a known sequence. The sequence may be obtained by making a cDNA from mRNA. The sequence may also be derived from a genomic DNA sequence. The sequence may be subcloned in a vector of choice . When isolating the sulfur-rich sunflower 2S albumin or sulfur- rich 10 kDa or 16 kDa rice prolamin gene from the genome, or subcloning these genes, the methodologies used would include identification of the gene by hybridization with probes, PCR, probe/primer/synthetic gene synthesis,
sequencing, molecular cloning and other techniques which are well-known to those skilled in molecular biology.
Once the gene of choice has been isolated, a copy of its sequence is placed into an expression vector by standard methods. For a general description of plant expression vectors, see Gruber et al . , "Vectors for Plant Transformation, " in METHODS IN PLANT MOLECULAR BIOLOGY AND BIOTECHNOLOGY 89-119 (CRC Press, 1993) . It is preferred to insert multiple copies of an expression cassette containing the gene to be introduced into an expression vector, preferably at least four copies. The selection of an appropriate expression vector will depend upon the method of introducing the expression vector into host cell-.' . A typical expression vector contains: prokaryotic
DNA elements coding for a bacterial replication origin and an antibiotic resistance gene to provide for the growth and selection of the expression vector in the bacterial host; a cloning site for insertion of the exogenous DNA sequence; eukaryotic DNA elements that control initiation of transcription of the exogenous DNA sequence, such as a promoter and an optional enhancer; and DNA elements that control the processing of transcripts, such as a transcription termination- polyadenylation sequence. The vector also could contain additional sequences that are necessary to allow for the eventual integration of the vector into a chromosome.
Expression of the gene sequence is under the control of a promoter. Examples of suitable promoters are the promotor for the small subunit of ribulose-1, 5-bis- phosphate carboxylase, promoters from tumor-inducing plasmids of Agrobacterium tu efaciens, such as the nopaline synthase and octopine synthase promoters, and viral promoters such as the cauliflower mosaic virus (CaMV) 19S and 35S promoters or the figwort mosaic virus 35S promoter. The promoter can be constitutive or inducible.
- 7 -
Especially preferred is a "seed tissue-preferred" or "seed tissue-specific" promoters, that is, promoters that drive high expression of the heterologous DNA segment in seed tissue where control of genes that are involved in seed metabolism is desired, and little or no expression in other parts of the plant. Manufacture of sulfur-rich proteins in other parts of the plant needlessly expends the plant's energy. Examples of known seed tissue- preferred or seed tissue-specific promoters include the soybean promoter of β-conglycinin, also known as the 7S protein, which drives seed-directed transcription (Bray, Planta 172: 364 (1987)) and seed-directed promoters from the zein genes of maize endosperm (Pedersen et al . , Cell 29: 1015 (1982)) . Dicot promoters are preferred for use in soybeans, and a particularly preferred promoter is the bean phaseolin promoter.
In addition to a suitable promoter, one or more enhancers are useful in the invention to increase transcrip ion of the introduced DNA segment. The enhancer or enhancer-like element can be inserted into the promoter to provide higher levels of transcription. Examples of such enhancers include inter alia , viral enhancers like those within the 35S promoter, as shown by Odell et al . , Plant Mol . Biol . 10: 263-72 (1988) , and an enhancer from an opine gene as described by Fromm et al . , Plant Cell 1: 977 (1989) .
Selectable marker genes, in physical proximity to the introduced DNA segment, are used to allow transformed cells to be recovered by either positive genetic selection or screening. The selectable marker genes also allow for maintaining selection pressure on a transgenic plant population, to ensure that the introduced DNA segment, and its controlling promoters and enhancers, are retained by the transgenic plant. Many of the commonly used positive selectable marker genes for plant transformation have been isolated from bacteria and code for enzymes that metabolically detoxify a selective chemical agent which may be an antibiotic or
a herbicide. Other positive selection marker genes encode an altered target which is insensitive to the inhibitor.
A preferred selection marker gene for plant transformation is the neomycin phosphotransferase II (nptll) gene, isolated from Tn5, which confers resistance to kanamycin when placed under the control of plant regulatory signals. Fraley et al . , Proc . Nat ' l Acad . Sci . USA 30: 4803 (1983) . Another useful selectable marker is the hygromycin phosphotransferase gene which confers resistance to the antibiotic hygromycin. Vanden Elzen et al . , Plan Mol . Biol . 5: 299 (1985) . Additional positive selectable markers genes of bacterial origin that confer resistance to antibiotics include gentamicin acetyl transferase, streptomycin phosphotransferase, aminoglycoside-3' -adenyl transferase and the bleomycin resistance determinant. Hayford et al . , Plant Physiol .
86: 1216 (1988) ; Jones et al . , Mol . Gen . Genet . 210: 86
(1987) ; Svab et al . , Plan t Mol . Biol . 14: 197 (1990) ; Hille et al . , loc . ci t . 7: 171 (1986) .
Other positive selectable marker genes for plant transformation are not of bacterial origin. These genes include mouse dihydrofolate reductase, plant 5-enolpyruvylshikimate-3-phosphate synthase and plant acetolactate synthase. Eichholtz et al . , Soma ti c Cell Mol . Genet . 13: 67 (1987) ; Shah et al . , Science 233: 478 (1986) ; Charest et al . , Plant Cell Rep . 8: 643 (1990) .
Another class of useful marker genes for plant transformation with the DNA sequence requires screening of presumptively transformed plant cells rather than direct genetic selection of transformed cells for resistance to a toxic substance such as an antibiotic. These genes are particularly useful to quantitate or visualize the spatial pattern of expression of the DNA sequence in specific tissues and are frequently referred to as reporter genes because they can be fused to a gene or gene regulatory sequence for the investigation of gene expression. Commonly used genes for screening
presumptively transformed cells include β-glucuronidase (GUS) , jS-galactosidase, luciferase, and chloramphenicol acetyltransferase. Jefferson, Plant Mol . Biol . Rep . 5: 387 (1987) ; Teeri et al . , EMBO J. 8: 343 (1989) ; Koncz et al . , Proc . Nat ' l Acad . Sci . USA 84: 131 (1987) ; De Block et al . , EMBO J. 3: 1681 (1984) . Another approach to the identification of relatively rare transformation events has been use of a gene that encodes a dominant constitutive regulator of the Zea mays anthocyanin pigmentation pathway. Ludwig et al . , Sci ence 247: 449 (1990) .
In order to create an expression vector containing the gene or genes of interest, an expression cassette first is made by inserting a cloned sunflower 2S albumin or rice prolamin gene into a plasmid under the control of a regulatory sequence. The resulting expression cassette can be ligated back to itself to produce an expression cassette with a tandem repeat of the cloned gene. A further ligation can be performed to generate a construct that contains four tandem copies of the gene. One or more copies of the expression cassette containing the introduced DNA segment corresponding to the sulfur-rich 2S albumin sunflower gene or sulfur-rich 10 kDa or 16 kDa rice prolamin gene then is transferred to an expression vector. In a preferred embodiment, the vector also contains a gene encoding a selection marker which is functionally linked to promoters that control transcription initiation. Preferably, a disarmed Ti- plasmid is used as a vector for foreign DNA sequences. To create a transgenic plant, an expression vector containing a sulfur-rich 2S albumin sunflower gene or sulfur-rich 10 kDa or 16 kDa rice prolamin gene can be introduced into protoplasts; into intact tissues, such as immature embryos and meristems; into callus cultures or into isolated cells. Preferably, expression vectors are inserted into intact tissues, particularly explants derived from hypocotyl or cotyledonary nodes of a germinated seed. In this regard, an explant is a piece
of tissue that is taken from a donor plant and is capable of producing callus in culture. Hypocotyl tissue is that portion of the stem of a plant embryo or seedling below the cotyledons and above the root . A cotyledon is an embryonic leaf, and a cotyledonary node is that part of the seedling between the embryonic axis and the cotyledons which botanically defines the division of the hypocotyl and the epicotyl , or embryonic shoot . General methods of culturing plant tissues are provided, for example, by Miki et al . , "Procedures for Introducing Foreign DNA into Plants," in METHODS IN PLANT MOLECULAR BIOLOGY AND BIOTECHNOLOGY 67-88 (CRC Press 1993) .
A preferred method for introducing an expression vector into plant tissue is direct infection or co- cultivation of plant tissue with A . tumefaciens that contains an expression vector with the gene of interest and associated regulatory elements. Horsch et al . , Science 227: 1229 (1985) . A preferred expression vector is the vector pARC12 (pl830) , a plasmid which is part of a binary Ti plasmid system of A . tumefaciens and which contains nopaline synthase/neomycin phosphotransferase II (NPTII) as a promoter and selectable marker for transformed plant cells.
The expression vector preferably is transformed into A . tumefaciens using a freeze-thaw technique, as described in PLANT MOLECULAR BIOLOGY (Gelvin and Schilperoort, eds., Kluwer Academic Publishers, 1988) .
After an A . tumefaciens strain is confirmed to contain a complete copy of the construct, the construct can be transferred to the target plant. A suitable model for demonstrating transformation of a plant by the sulfur-rich sunflower 2S albumin and sulfur-rich rice prolamin genes is Agrobacterium-mediated transformation of the tobacco plant, Nicotiana tabacum . In this model, an Agrobacteriu strain confirmed to contain the construct is used to inoculate wounded tobacco plants to generate the transgenic events. Spielmann et al . Mol . Gen . Genet . 205: 34 (1986) .
When AgrojbacϋeriuiT? is used to transfer an expression vector to soybean, induction of the virulence (vir) genes in Agrobacterium leads to enhanced transformation. Cultured soybean cells lack or have a limiting amount of the necessary signal molecules to initiate the transformation process, and induction of the vir genes is necessary to achieving successful transformation. Various physical parameters can be used to induce the vir genes. Various compounds can be used, individually or in combination, to induce the vir gene. Exemplary of such compounds are phenolic compounds such as acetosyringone, α-hydroxyacetosyringone, acetovanillone, syringaldehyde, syringic acid and sinapinic acid.
Low temperatures and low pH during co-cultivation also lead to improved transformation, presumably as a result of an effect on the vir genes. Temperatures below 26° result in more effective transformation, and a temperature of about 20° is preferred. Buffering at a pH below 6.0, preferably a pH of about 5.5, also improves transformation efficiency.
Transformation of soybean by Agrobacterium also is dependent upon concentration of bacteria in the inoculum. In general, higher numbers of bacteria result in more transformation events. Preferably an inoculation period of at least 30-minutes, and a concentration of bacteria of at least 3xl08 viable cells/ml are used.
For transformation of corn, techniques other than AgrrpJbac erium-mediated transformation are preferred. An especially preferred methodology in this regard entails subjecting an exposed corn meristem to biolistic bombardment, in order to target non-differentiated meristem cells for transformation, as described in international application PCT 96/04392. According to this approach, meristem tissue is manipulated following bombardment in order to enlarge transgenic sectors, either through selection and/or through effecting a proliferation from the tissue of shoots or multiple meristems per se . The shoot population thus obtained
then is screened, by means of a nonlethal enrichment assay, to identify either chimeric sectors that will contribute to germline transmission, or non-sectored, periclinal chimeras that will by definition transmit to progeny. Increased time in culture, under selection, enhances the prospects for sectoral-to-periclinal conversions, and also selects for Ll-to-L2 conversions which, through a shift in position, ultimately contribute to the germline. After screening, transgenic plants are established from transformed explants by conventional techniques known to the skilled artisan. A preferred technique is cultivation of transformed explants in liquid counterselection medium, followed by transfer to solidified selection medium. The process is repeated as described in the art for identification by transgenic markers such as 3-glucuronidase ( gus) . McCabe et al . , Bio/Technology 6: 922 (1988) . Shoots are induced in transgenic explants by known methods. Wright et al . , Plan t Cell Rep . 5: 150 (1986) ; Barwale et al . , Planta 167: 473 1986) . The shoots are excised and, by the addition of pyroglutamic acid to a hormone-enriched growth medium, roots readily are induced. Whole mature, reproductive plants are produced after transfer to greenhouse culture in soil .
Seed from transgenic plants according to the invention contain significant levels of sulfur-containing amino acids, particularly methionine. Expression of the sulfur-rich genes was accompanied by a concomitant decrease in trypsin and chymotrypsin inhibitor activities. These endogenous inhibitors are relatively rich in sulfur-containing amino acids, and the overexpression of the introduced genes may be depleting the normal free sulfur pools in the seed, with the result that sulfur is being scavenged from endogenous proteins. The tran genic plants appear to accumulate the heterologous proteins at the expense of certain endogenous proteins to maintain a homeostatic condition.
The changes produce no apparent effect on the viability of the transgenic plant or on the total seed protein.
Analysis of seed proteins from transgenic plants reveals no larger precursor proteins, suggesting that the transgenic protein is being processed completely, as it would be in the plant of origin. Amino acid analysis of seeds from transgenic plants shows no significant changes as compared to controls, except for increased levels of methionine. While the present invention has been described in detail with respect to particular preferred embodiments, it should be understood that such description is presented by way of illustration and not limitation. Many changes and modifications within the scope of the present invention may be made without departing from the spirit thereof, and the invention includes all such modifications. Thus, while A . tumefaciens is a preferred vector, other types of vectors can be used for transformation by procedures such as direct gene transfer, as described, for example, in PCT application WO 85/01856 and in European application 0 275 069; in vi tro protoplast transformation, which is the subject of U.S. patent No. 4,684,611, for instance; plant virus- mediated transformation, illustrated in European application 0 67 553 and U.S. patent No. 4,407,956; and liposome-mediated transformation according to U.S. patent No. 4,536,475, among other disclosures. Direct transfer methods also may be employed, such as microprojectile- mediated delivery, DNA injection, and electroporation. See, for example, Gruber et al . and Miki et al . , both cited above, and Klein et al . , Bio/Technology 10: 268 (1992) .
The present invention is further described by reference to the following, illustrative example.
EXAMPLE: ACROBACTERIUM-MEDIATED TRANSFORMATION OF TOBACCO OR SOYBEAN TO PRODUCE A TRANSGENIC PLANT THAT HAS A HIGH CONCENTRATION OF SULFUR-CONTAINING AMINO ACIDS
A. Creation of expression vector that contains sulfur-rich sunflower 2S albumin and rice prolamin genes
Full-length cDNA clones for the 10 kDa rice prolamin and sunflower SFA-8 proteins were obtained using RT-PCR with first strand cDNA as template and gene-specific primers designed against published sequences. See Matsumura et al . and Lilley et al . , supra . The resulting PCR products were subcloned into pBluescript SKII and confirmed by sequence analysis. The genes were transferred into p4752, which contains the 5' and 3' regulatory sequences from phaseolin. Sengupta-Gopalan et al . , Proc . Na t ' l Acad . Sci . USA 82: 3320 (1985) . The resulting expression cassettes contained SFA-8 (p6445) and 10 kDa rice prolamin (p6465) under control of the phaseolin regulatory sequences. p6445 and p6465 were then ligated back to themselves to produce p6668 and p6670, respectively, which contained tandem repeats of the expression cassettes. A final set of ligations was performed with p6668 and p6670 to generate p7518 and p7519, respectively, constructs which contain four tandem copies of the expression cassettes.
The constructs containing the four tandem copies were then transferred to the binary vector pARC12
(pl830) , a vector which contains the NPTII selectable marker for plant selection. The resulting binary vectors for 4X SFA-8 and 4X 10 kDa rice prolamin are denoted p6704 and p7499, respectively. These vectors were transformed into Agrobacterium tumefaciens strain LBA4404 by a freeze-thaw method (PLANT MOLECULAR BIOLOGY, op ci t . ) , and presence of a complete copy of the 4X construct was confirmed.
B. Explant preparation, transformation and transgenic plant recovery
Tobacco
Tobacco plants (Ni cotiana tabacum) var. Xanthii, were cultured from 1 cm apical or axillary explants on OMS, according to Murashige et al . , Physiologia Plantarum, 15:473 (1962) , in a Magenta Box (Magenta Corp., Chicago, 111.) at 27°C with a 16 hour light/8 hour dark photoperiod. The first four fully expanded leaves below the apex (leaves 3, 4, 5 or 6) were removed. Leaves were placed, one at a time, in a 100 mm petri dish with several Whatman #1 filter discs, 7cm, soaked with liquid medium. A sterile, sharp, #2 cork bore (0.5 cm i.d.) was used to punch leaf discs, avoiding the midrib and veins. Discs were held on filter paper at 100% humidity in a separate petri dish with Whatman filters and liquid medium.
Overnight cultures of A . tumefaciens LBA4404 harboring p6704 and p7499, respectively, were grown to log phase in Minimal A medium containing tetracycline, 1.0 μg/ml. Cultures were pooled and an optical density at 550 nm was measured. Culture density was adjusted by dilution with liquid medium to about 5 x 105 bacteria/ml. Leaf discs were inoculated by dipping them individually in a suspension of Agrobacterium harboring the 4X construct . Each disc was held submerged in the suspension for 0.5 -1.0 second, to ensure that all edges were infected. Each disc then was placed on a filter on cocultivat-ion medium the induces regeneration of shoots in a petri dish. The medium was supplemented with phytohor ones and included major salts and MS micronutrients (Murashiga, op . ci t . ) supplemented with sucrose, 3.0% w/v; naphthalene acetic acid (NAA) , 0.1 mg/L and 6-benzylaminopurine (BAP) , 1.0 mg/L. The medium was buffered to pH 5.7. The filter was dry enough to wick away excess inoculum. Ten to twelve discs per 7 cm filter per 100 mm plate were plated. The petri dishes
were covered with parafilm and kept in low light at 28°C for two days.
After two days the explants were moved to a liquid counterselection medium, a medium having the same basic composition as that used during cocultivation, but with the addition of cefotaxime, 500 μg/ml and vancomycin, 100 μg/ml. The discs were washed with gentle continuous gyratory shaking for 3-6 hours with at least one change of liquid medium. The discs then were placed on solid medium, a medium having the same basic composition as that used during cocultivation, but with the addition of vancomycin, 100 μg/ml and carbenicillin, 500 μ/ml . Excess liquid was evaporated before plating ten to twelve discs per 100 mm plate. The explants were cultures for 3 days at 28°C in low light .
Discs were transferred to solid selection medium, a medium having the same basic composition as that used during cocultivation, but with the addition of vancomycin, 100 μg/ml; carbenicillin, ^00 μg/ml; and kanamycin, 100 μg/ml. The discs were cultured at 26°C in high light with 16 hour light/8 hour dark photoperiod.
Transformed sectors became visible approximately two weeks later. Shoots appeared soon after callus and these were removed from the callus and place on hormone-free medium for rooting. Soybean
Seeds of soybean ( Glycine max) , var. PHI9341, were surface sterilized by exposure to chlorine gas evolved in a glass bell jar. Gas was produced by adding 3.5 ml hydrochloric acid (34-37% w/w) to 100 ml to sodium hypochlorite (5.25% w/w) . Exposure was for 16-20 hours in a container approximately one cubic foot in volume. Surface sterilized seed was stored in petri dishes at room temperature. Seed was germinated by plating of 1/10 strength agar solidified medium according to Gamborg (B5 basal medium with minimal organics, Sigma Chemical Co., cat. no. G5893, 0.32 gm/L; sucrose, 0.2% w/v and
2- [N-morp olino] ethanesulfonic acid] (MES) , 3.0 mM without plant growth regulators and culturing at 28°C with a 16 hour day length and cool white fluorescent illumination of approximately 20 μEm2S' . After three or four days, seed was prepared for co-cultivation. The seed coat was removed and the elongating radicle was removed 3-4 mm below the cotyledons. Ten prepared seed were held in each of several petri dishes.
Overnight cultures of A . tumefaciens LBA4404 harboring p6704 and p7499, respectively, were grown to log phase in Minimal A medium containing tetracycline, 1.0 μg/ml. Cultures were pooled and an optical density at 550 nm was measured. An amount of culture sufficient to collect upon sedimentation between 1.0 and 2.0 x 1010 cells, where O.D. 550 1.0 = 1.4 x IO9 cells/ml, was placed in a 15 ml conical centrifuge tube, and spun down at 6000 g for 10 minutes. After centrifugation the supernatant was decanted and the tubes were held at room temperature until inoculum was needed, but not longer than one hour.
Inoculations were conducted in batches such that each plate of seed was treated with a newly resuspended pellet of A . tumefaciens harboring the 4X construct. One at a time the pellets were resuspended in 20 ml inoculation medium. Inoculation medium consisted of B5 salts (B5893) , 3.2 gm/L; sucrose, 2.0% w/v; BAP, 44 μM; and indolebutyric acid (IBA) , 0.5 μM. Acetosyringone (AS) , 100 μM was added and the medium was buffered to pH 5.5 with MES, 10 . The mixture was resuspended by vortexing and the inoculum was poured into a petri dish containing prepared seed and the cotyledonary nodes were macerated with a surgical blade. This was accomplished by dividing seed in half by longitudinal section through the shoot apex, preserving the two whole cotyledons. The two halves of the shoot apex were broken off at their respective cotyledons by prying them away with a surgical blade. The cotyledonary node was then macerated with the
- 18 -
surgical blade by repeated scoring along the axis of symmetry. Care was taken not to cut entirely through the explant to the abaxial side. Twenty explants were prepared in roughly five minutes and then incubated for 30 minutes at room temperature without agitation. Additional plates were prepared during this time. After 30 minutes the explants were transferred to plates of the same medium solidified with Gelrite (Merck & Co . , Inc.) , 0.2% w/v. Explants were embedded with the adaxial side up and level with the surface of the medium and cultured at 22°C for three days under cool white fluorescent light, approximately 20 μEm2S! .
After three days the explants were moved to liquid counterselection medium. Counterselection medium consisted of B4 salts (G5893) , 3.2 gm/L; sucrose, 2.0% w/v; BAP, 5.0 μM; IBA, 0.5 μM; vancomycin, 200 μ/ml ; cefotaxime, 500 μg/ml and was buffered to pH 5.7 with MES, 3 mM. Ten explants were washed in each petri dish with constant, slow gyratory agitation at room temperature for four days. Counterselection medium was replaced four times.
The explants were picked to agarose solidified selection medium. Selection medium consisted of B5 salts (G5893) , 3.2 gm/L; sucrose, 2.0% w/v; BAP, 5.0 μM; IBA, 0.5 μM; kanamycin sulfate, 50 μg/ml; vancomycin, 100 μg/ml; cefotaxime, 30 μg/ml; timentin, 30 μg/ml and was buffered to pH 5.7 with MES, 3.0 mM. Selection medium was solidified with SeaKem agarose, 0.3% w/v. The explants sere embedded in the medium, adaxial side down and cultured at 28°C with a 16 hour day length and cool white fluorescent light, of 60-80 μEm2S' .
After two weeks explants were washed with liquid medium on the gyratory shaker. This time the wash was conducted overnight in counterselection medium containing kanamycin sulfate, 50 μg/ml. The following day explants were picked to agarose solidified selection medium. Again they were embedded in the medium, adaxial side down, and cultured as before for another two weeks.
- 19 -
After one month on selective media transformed tissue became visible as green sectors of regenerating tissue against a background of bleached, less healthy tissue. Explants without green sectors were discarded, explants with green sectors were transferred to elongation medium. Elongation medium consisted of B5 salts (G5893) , 3.2 gm/L; sucrose, 2.0% w/v; IBA, 3.3 μM; gibberellic acid, 1.7 μM; vancomycin, 100 μg/ml; cefotaxime, 30 μg/ml; timentin, 30 μg/ml and was buffered to pH 5.7 with MES, 3.0 mM. Elongation medium was solidified with gelrite, 0.2% w/v. Explants were embedded adaxial side up and culture as before. Culture was continued on this medium with transfers to fresh plates every two weeks. When shoots became 0.5 cm in length they were excised at the base and placed in rooting medium in 13 x 100 mm test tubes. Rooting medium consisted of B5 salts (G5893), 3.2 gm/L; sucrose, 15 gm/L; nicotinic acid, 20 μM; pyroglutamic acid (PGA) , 900 mg/L and IBA, 10 μM. The medium was buffered to pH 5.7 with MES, 3.0 mM and solidified with GelRite, 0.2% w/v. After ten days the shoots were transferred to the same medium without IBA or PGA. Shoots were rooted and held in these tubes under the same environmental conditions as before. Once a root system was well established, the plantlet was transferred to sterile soil mix in plant cons (ICN Biomedicals, Inc.; catalogue Nos. 26-720 and 1-02) . Temperature, photoperiod and light intensity remained the same as before. Under these conditions the regenerants became vigorous, somewhat small, but mostly normal plants. When their root systems became well established, a corner of the plant con was cut off and the plants were gradually hardened off in an environmental chamber or greenhouse. Finally they were potted in soil mix and grown to maturity, bearing seed, in a greenhouse.
C. Analysis of seeds produced by transgenic plants
Mature seed from several independent transgenic lines containing either the SFA-8 or 10 kDa rice prolamin genes were extracted in 2X Laemmli buffer. Proteins were quantitated using a modified Lowry kit from Bio-Rad using bovine serum albumin as a standard. Equal amounts of protein were loaded onto 4-20% Tris-glycine polyacrylamide gels. Molecular weight standards in the range of 3-116 kD were obtained from Novex and run alongside the protein samples. Gels were run in duplicate with one being electrophoretically transferred to Immobilon PVDF membrane for western blotting and the other being used for Coomassie staining. Western blots were performed using affinity purified antibodies against either the sunflower 2S albumin or rice prolamin and the signal was detected by the Western-Light Chemiluminescent Detection System from Tropix, Inc. (Bedford, MA) as per the manufacturer's instructions.
Total amino acid composition can be determined by acid hydrolysis of tobacco or soybean meal by standard protocols. Seed proteins also can be analyzed for trypsin inhibitory activity according to the previously described protocols of Kollipara et al . , J. Agri cul . Food Chem . 40:2356 (1992) . Similarly chymotrypsin inhibitory assays can be done according to Geiger, Chymotrypsin. In "Methods of Enzymatic Analysis," pp. 99-109 (1984) .
Analysis of seed proteins from 6 independent transgenic tobacco lines that contain the gene for SFA-8 revealed a band that comigrated with purified SFA-8. No signal was detected in protein samples from non- transformed tobacco. By comparing the intensity of the immunodetected band to a dilution series of purified SFA-8, the transgenic SFA-8 protein accumulated as a percentage of total seed protein was calculated to be 5-10%. No larger precursor proteins were detected, indicating that the transgenic is processed as it normally is in sunflower.
Similar results were obtain for transgenic tobacco plants expressing the rice prolamin gene. A band was
detected that comigrated with the purified rice prolamin in all of the transgenic tobacco lines. No signal was detected in protein samples from non-transformed tobacco. Using a dilution series of purified rice prolamin as a standard, the transgenic rice prolamin protein accumulated as a percentage of total seed protein was calculated to be 1-5%. Surprisingly, no larger precursor proteins were detected, indicating that the transgenic tobacco plant, a dicot, processed the protein in the same way as rice, a monocot.
Claims (15)
1. A transgenic plant that contains a DNA molecule comprised of (A) a nucleotide sequence corresponding to a sulfur-rich rice prolamin gene or sulfur-rich sunflower 2S albumin gene and (B) a promoter, operably linked to said nucleotide sequence, to effect expression thereof by said transgenic plant.
2. A transgenic plant according to claim 1, wherein said plant is a soybean plant.
3. A transgenic plant according to claim 2, wherein said nucleotide sequence corresponds to a sulfur- rich 10 kDa rice prolamin gene.
4. A transgenic plant according to claim 3, wherein said nucleotide sequence is a sulfur-rich 10 kDa rice prolamin gene as shown in Figure 2.
5. A transgenic plant according to claim 2, wherein said nucleotide sequence corresponds to one of SFA-7 and SFA-8.
6. A transgenic plant according to claim 5, wherein said nucleotide sequence is SFA-8.
7. A transgenic plant according to claim 1, wherein said plant is a corn plant.
8. A seed produced by a plant as claimed in claim 1.
9. A method of increasing the content of sulfur- containing amino acids in an animal feed, comprising the steps of (i) providing seeds from a plurality of plants, at least some of which plants contain a DNA molecule comprised of a nucleotide sequence corresponding to a sulfur-rich rice prolamin gene or sulfur-rich sunflower 2S albumin gene, operably linked to a promoter to effect expression of said nucleotide sequence by said plants; and (ii) processing said seeds into animal feed.
10. A method according to claim 8, wherein said plants are soybean plants.
11. A method according to claim 10, wherein said nucleotide sequence corresponds to a sulfur-rich 10 kDa rice prolamin gene .
12. A method according to claim 9, wherein said nucleotide sequence corresponds to a sulfur-rich sunflower 2S albumin gene.
13. A feed product that contains soybean meal obtained from seed of a transgenic plant according to claim 1.
14. A feed product according to claim 13, wherein said feed product has not been supplemented by addition of sulfur-containing amino acids.
15. A method of altering a plant to produce seed that contains levels of sulfur-containing amino acids that are higher than those of an unaltered plant, comprising the steps of (i) providing cells or tissues of a plant transformed with an expression vector that contains a nucleotide sequence corresponding to a sulfur- rich rice prolamin gene or sulfur-rich sunflower 2S albumin gene; (ii) propagating plants from said transformed cells or tissue; and (iv) selecting for further propagation those plants that produce sulfur-rich rice prolamin or sulfur-rich sunflower 2S albumin.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1656096P | 1996-04-30 | 1996-04-30 | |
US60016560 | 1996-04-30 | ||
PCT/US1997/006180 WO1997041239A2 (en) | 1996-04-30 | 1997-04-24 | Transgenic plants with enhanced sulfur amino acid content |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2729597A true AU2729597A (en) | 1997-11-19 |
Family
ID=21777761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27295/97A Abandoned AU2729597A (en) | 1996-04-30 | 1997-04-24 | Transgenic plants with enhanced sulfur amino acid content |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0929685A2 (en) |
AU (1) | AU2729597A (en) |
BR (1) | BR9710839A (en) |
CA (1) | CA2253292A1 (en) |
DE (1) | DE929685T1 (en) |
ES (1) | ES2142780T1 (en) |
HU (1) | HUP0202676A2 (en) |
WO (1) | WO1997041239A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8148398A (en) * | 1997-07-15 | 1999-02-10 | Dow Agrosciences Llc | Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds |
AUPO930597A0 (en) | 1997-09-19 | 1997-10-09 | Commonwealth Scientific And Industrial Research Organisation | Method for altering seed compostion |
US7053282B1 (en) | 1998-02-09 | 2006-05-30 | Pioneer Hi-Bred International, Inc. | Alteration of amino acid compositions in seeds |
US6576819B1 (en) | 1999-02-18 | 2003-06-10 | Pioneer Hi-Bred International, Inc. | Methods for modulating the levels of organic sulfur compounds in plants by transforming with (P)APS reductase DNA |
FR2803592A1 (en) | 2000-01-06 | 2001-07-13 | Aventis Cropscience Sa | NOVEL DERIVATIVES OF 3-HYDROXYPICOLINIC ACID, PROCESS FOR THEIR PREPARATION AND FUNGICIDAL COMPOSITIONS CONTAINING SAME |
FR2815969B1 (en) | 2000-10-30 | 2004-12-10 | Aventis Cropscience Sa | TOLERANT PLANTS WITH HERBICIDES BY METABOLIC BYPASS |
US7038109B1 (en) | 2001-03-29 | 2006-05-02 | Pioneer Hi-Bred International, Inc. | Enzymatic methods for modulating the levels of organic sulfur compounds in plants |
AR075465A1 (en) | 2008-10-22 | 2011-04-06 | Basf Se | USE OF SULFONILUREA HERBICIDES IN CULTIVATED PLANTS |
AR075466A1 (en) | 2008-10-22 | 2011-04-06 | Basf Se | USE OF AUXINE TYPE HERBICIDES IN CULTIVATED PLANTS |
AR080105A1 (en) | 2010-02-02 | 2012-03-14 | Bayer Cropscience Ag | SOFT TRANSFORMATION USING HYDROPHENYL PIRUVATO DIOXYGENASE (HPPD) INHIBITORS AS SELECTION AGENTS |
AR093243A1 (en) | 2012-10-01 | 2015-05-27 | Basf Se | USE OF N-TIO-ANTRANILAMIDE COMPOUNDS IN CULTIVATED PLANTS |
WO2014079820A1 (en) | 2012-11-22 | 2014-05-30 | Basf Se | Use of anthranilamide compounds for reducing insect-vectored viral infections |
EP3028573A1 (en) | 2014-12-05 | 2016-06-08 | Basf Se | Use of a triazole fungicide on transgenic plants |
WO2016091674A1 (en) | 2014-12-12 | 2016-06-16 | Basf Se | Use of cyclaniliprole on cultivated plants |
WO2016162371A1 (en) | 2015-04-07 | 2016-10-13 | Basf Agrochemical Products B.V. | Use of an insecticidal carboxamide compound against pests on cultivated plants |
EP3338552A1 (en) | 2016-12-21 | 2018-06-27 | Basf Se | Use of a tetrazolinone fungicide on transgenic plants |
AR115870A1 (en) | 2018-07-31 | 2021-03-10 | Sumitomo Chemical Co | METHOD FOR CONTROLLING SOYBEAN ROY FUNGUS THAT HAS RESISTANCE TO SITE INHIBITOR Qₒ |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ225044A (en) * | 1987-06-19 | 1990-01-29 | Plant Cell Res Inst | Bertholletia excelsa dna molecule; sulphur rich storage protein |
EP0318341B1 (en) * | 1987-10-20 | 1996-07-31 | Plant Genetic Systems, N.V. | A process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins in said plants |
MX9200621A (en) * | 1991-02-14 | 1993-02-01 | Du Pont | GENE OF A PROTEIN WITH HIGH SULFUR CONTENT OF A SEED AND METHOD TO INCREASE THE SULFUR CONTENT IN AMINO ACIDS OF PLANTS. |
JPH07213185A (en) * | 1994-02-03 | 1995-08-15 | Sumitomo Chem Co Ltd | Plant improved in content of amino acid containing sulfur and method for improvement |
-
1997
- 1997-04-24 BR BR9710839-1A patent/BR9710839A/en not_active Application Discontinuation
- 1997-04-24 AU AU27295/97A patent/AU2729597A/en not_active Abandoned
- 1997-04-24 HU HU0202676A patent/HUP0202676A2/en unknown
- 1997-04-24 EP EP97921184A patent/EP0929685A2/en not_active Withdrawn
- 1997-04-24 ES ES97921184T patent/ES2142780T1/en active Pending
- 1997-04-24 WO PCT/US1997/006180 patent/WO1997041239A2/en not_active Application Discontinuation
- 1997-04-24 CA CA002253292A patent/CA2253292A1/en not_active Abandoned
- 1997-04-24 DE DE0929685T patent/DE929685T1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2253292A1 (en) | 1997-11-06 |
ES2142780T1 (en) | 2000-05-01 |
BR9710839A (en) | 2000-01-11 |
DE929685T1 (en) | 2000-08-17 |
EP0929685A2 (en) | 1999-07-21 |
WO1997041239A2 (en) | 1997-11-06 |
HUP0202676A2 (en) | 2002-12-28 |
WO1997041239A3 (en) | 1998-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6080913A (en) | Binary methods of increasing accumulation of essential amino acids in seeds | |
US7122658B1 (en) | Seed-preferred regulatory elements and uses thereof | |
US6127600A (en) | Methods of increasing accumulation of essential amino acids in seeds | |
US6903205B2 (en) | Seed-preferred promoters from end genes | |
US7189889B2 (en) | Methods for improving seed characteristics | |
US7217858B2 (en) | S-adenosyl-L-methionine synthetase promoter and its use in expression of transgenic genes in plants | |
EP0754236B1 (en) | Reduction of endogenous seed protein levels in plants | |
US7321031B2 (en) | Seed preferred regulatory elements | |
JP2011101653A (en) | Method and composition for expression of transgene in plant | |
AU2729597A (en) | Transgenic plants with enhanced sulfur amino acid content | |
US7211712B2 (en) | Seed-preferred regulatory elements | |
US7700836B2 (en) | Seed-preferred regulatory elements | |
JP2002518055A (en) | Plant selectable marker and plant transformation method | |
TWI534265B (en) | Method, genetic construct and transgenic p;ant cell for manipulating fructan biosynthesis in photosynthetic cells of a plant | |
US5824872A (en) | A constitutive promoter from tobacco | |
US7897841B2 (en) | Seed-preferred regulatory elements | |
US7081566B2 (en) | Seed preferred regulatory elements | |
KR102000471B1 (en) | Constitutive promoter derived from chrysanthemum and use thereof | |
KR20200000018A (en) | OsNFY16 promoter specific for plant seed embryo and uses thereof | |
JP2002540773A (en) | Insect virus vectors and uses thereof | |
MXPA98009091A (en) | Transgenic plants with increased content deaminoacidos de azu | |
US7329798B2 (en) | Harvest-inducible regulatory elements and methods of using same | |
KR101825960B1 (en) | Root―specific promoter derived from Oryza sativa and use thereof | |
US20110055977A1 (en) | Enhancement of Reproductive Heat Tolerance in Plants | |
US7064247B1 (en) | Nucleic acid encoding maize endoplasmic reticulum oxidoreductin and method of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |